| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 1 | 2016 | 2016 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 6 | 5 | 2001 | 2009 | ||||||||
|
sodium voltage-gated channel alpha subunit 4 | 0.554 | 0.731 | 1.3E-02 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2004 | 2008 | ||||||||
|
transcription factor AP-2 alpha | 0.488 | 0.769 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2015 | 2015 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
leucine zipper like transcription regulator 1 | 0.547 | 0.808 | 1.0E-92 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
contactin associated protein 1 | 0.554 | 0.577 | 3.4E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
cyclin dependent kinase 13 | 0.606 | 0.692 | 0.91 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
kynureninase | 0.617 | 0.692 | 4.2E-18 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
ribosomal protein S6 kinase A3 | 0.491 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
TATA-box binding protein associated factor 1 | 0.581 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
SRY-box transcription factor 11 | 0.494 | 0.808 | 0.86 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
solute carrier family 6 member 8 | 0.476 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
solute carrier family 12 member 6 | 0.603 | 0.500 | 1.1E-02 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
T-box transcription factor 2 | 0.544 | 0.769 | 0.99 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
polycomb group ring finger 2 | 0.579 | 0.615 | 0.86 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
elongation factor Tu GTP binding domain containing 2 | 0.647 | 0.462 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
post-GPI attachment to proteins phospholipase 3 | 0.628 | 0.731 | 1.9E-03 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
phospholipase A2 group VI | 0.476 | 0.846 | 2.5E-10 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
transcription factor AP-2 beta | 0.570 | 0.769 | 0.99 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
euchromatic histone lysine methyltransferase 1 | 0.460 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
thioredoxin domain containing 15 | 0.736 | 0.615 | 9.6E-03 |
|
disease | 0.100 | None | 0 | 1 |